GlassScriptPhysician profile
Arleene E Djordjevic
NPI 1558750935
$1,289.21
in general payments reported to CMS, 2019-2025
10 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $527 · 2024: $375 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $318.74 | 2023-2025 | |
| Amgen INC. | $260.43 | 2023-2025 | Evenity, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $221.53 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Teva Pharmaceuticals USA, INC. | $187.69 | 2024-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Viiv Healthcare Company | $147.97 | 2024-2025 | Dovato, Rukobia, Apretude |
| Merck Sharp & Dohme LLC | $70.44 | 2023-2024 | Delstrigo, Pifeltro, Dificid |
| Lilly USA, LLC | $32.21 | 2024 | Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $19.48 | 2025 | Abilify Maintena, Abilify Asimtufii |
| Jazz Pharmaceuticals INC. | $15.89 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $14.83 | 2024 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arleene Djordjevic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.